Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics.
about
Concentrations of Pro-Inflammatory Cytokines Are Not Associated with Senescence Marker p16INK4a or Predictive of Intracellular Emtricitabine/Tenofovir Metabolite and Endogenous Nucleotide Exposures in Adults with HIV InfectionMechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic ControllersNormal T-cell activation in elite controllers with preserved CD4+ T-cell countsSerum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV.Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered.Direct Targeting of Macrophages With Methylglyoxal-Bis-Guanylhydrazone Decreases SIV-Associated Cardiovascular Inflammation and Pathology.Increased frequencies of CD8+CD57+ T cells are associated with antibody neutralization breadth against HIV in viraemic controllers.Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.Sex Differences in Select Non-communicable HIV-Associated Comorbidities: Exploring the Role of Systemic Immune Activation/Inflammation.Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers.High Plasma Levels of sTNF-R1 and CCL11 Are Related to CD4+ T-Cells Fall in Human Immunodeficiency Virus Elite Controllers With a Sustained Virologic Control.Increased Systemic Inflammation and Gut Permeability Among Women With Treated HIV Infection in Rural UgandaSex Differences in HIV Infection: Mystique Versus MachismoUnderstanding the CD8 T-cell response in natural HIV controlCurrent Treatment Options for HIV Elite Controllers: a Review
P2860
Q28468505-15008B4E-B5D8-4751-9879-313B2490BC44Q33828507-BF0CBAD4-77CA-4444-89CF-7E6D9A251748Q36638690-669FFE37-D102-4C9F-B9C1-C8A12DFD9BC1Q37294964-385BFF4D-F49D-431B-9E98-08FE41A2FFCEQ38414358-1828310B-0C80-4639-8F2F-3C6F9D6496C3Q38988925-966EC055-241D-4817-9C10-A721623FA9B4Q39113783-87595F31-1AE3-4774-AAEB-E3B7CC0185D3Q47174478-46C4143B-FE04-44A4-9C53-201D4EC0FF83Q47597201-1DC3C8DA-6451-4844-861B-C03D54CE2F3FQ52680990-062FDE64-B0B3-417E-AD62-E9805411DBBBQ55400910-203EC5A0-729A-4F08-A8E9-277154EC9FEFQ56334211-7DB81247-65E6-4D2C-9F0B-528C40D579E5Q56996082-B82FB543-7D24-4FD9-A6F7-1C6F20771DEDQ57177414-02F1B391-939D-42DB-B944-AF9372794BD5Q57825309-7431353D-A022-4F0C-838B-056FCD1B1A87
P2860
Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Differential levels of soluble ...... oller status and demographics.
@ast
Differential levels of soluble ...... oller status and demographics.
@en
type
label
Differential levels of soluble ...... oller status and demographics.
@ast
Differential levels of soluble ...... oller status and demographics.
@en
prefLabel
Differential levels of soluble ...... oller status and demographics.
@ast
Differential levels of soluble ...... oller status and demographics.
@en
P2093
P2860
P356
P1476
Differential levels of soluble ...... oller status and demographics.
@en
P2093
Alan Landay
Andrea Heisey
Anne-Sophie Dugast
Daniel R Kuritzkes
Galit Alter
Heather J Ribaudo
Jill Plants
Jonathan Z Li
Kelly B Arnold
P2860
P304
P356
10.1093/OFID/OFU117
P577
2015-01-13T00:00:00Z